GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000003 | Reproduction |
| Process | GO:0000122 | Negative regulation of transcription by RNA polymerase II |
| Process | GO:0000902 | Cell morphogenesis |
| Process | GO:0000904 | Cell morphogenesis involved in differentiation |
| Process | GO:0001501 | Skeletal system development |
| Process | GO:0001503 | Ossification |
| Process | GO:0001525 | Angiogenesis |
| Process | GO:0001568 | Blood vessel development |
| Process | GO:0001569 | Branching involved in blood vessel morphogenesis |
| Process | GO:0001570 | Vasculogenesis |
| Process | GO:0001649 | Osteoblast differentiation |
| Process | GO:0001654 | Eye development |
| Process | GO:0001655 | Urogenital system development |
| Process | GO:0001656 | Metanephros development |
| Process | GO:0001657 | Ureteric bud development |
| Process | GO:0001658 | Branching involved in ureteric bud morphogenesis |
| Process | GO:0001666 | Response to hypoxia |
| Process | GO:0001667 | Ameboidal-type cell migration |
| Process | GO:0001708 | Cell fate specification |
| Process | GO:0001755 | Neural crest cell migration |
| Process | GO:0001763 | Morphogenesis of a branching structure |
| Process | GO:0001775 | Cell activation |
| Process | GO:0001822 | Kidney development |
| Process | GO:0001823 | Mesonephros development |
| Process | GO:0001838 | Embryonic epithelial tube formation |
| Process | GO:0001841 | Neural tube formation |
| Process | GO:0001889 | Liver development |
| Process | GO:0001942 | Hair follicle development |
| Process | GO:0001944 | Vasculature development |
| Process | GO:0001947 | Heart looping |
| Process | GO:0002009 | Morphogenesis of an epithelium |
| Process | GO:0002052 | Positive regulation of neuroblast proliferation |
| Process | GO:0002053 | Positive regulation of mesenchymal cell proliferation |
| Process | GO:0002076 | Osteoblast development |
| Process | GO:0002244 | Hematopoietic progenitor cell differentiation |
| Process | GO:0002320 | Lymphoid progenitor cell differentiation |
| Process | GO:0002360 | T cell lineage commitment |
| Process | GO:0002376 | Immune system process |
| Process | GO:0002520 | Immune system development |
| Process | GO:0002521 | Leukocyte differentiation |
| Process | GO:0002682 | Regulation of immune system process |
| Process | GO:0002683 | Negative regulation of immune system process |
| Process | GO:0002684 | Positive regulation of immune system process |
| Process | GO:0002694 | Regulation of leukocyte activation |
| Process | GO:0002695 | Negative regulation of leukocyte activation |
| Process | GO:0002696 | Positive regulation of leukocyte activation |
| Process | GO:0003002 | Regionalization |
| Process | GO:0003006 | Developmental process involved in reproduction |
| Process | GO:0003007 | Heart morphogenesis |
| Process | GO:0003140 | Determination of left/right asymmetry in lateral mesoderm |
| Process | GO:0003143 | Embryonic heart tube morphogenesis |
| Process | GO:0003156 | Regulation of animal organ formation |
| Process | GO:0003401 | Axis elongation |
| Process | GO:0006355 | Regulation of transcription, DNA-templated |
| Process | GO:0006357 | Regulation of transcription by RNA polymerase II |
| Process | GO:0006508 | Proteolysis |
| Process | GO:0006606 | Protein import into nucleus |
| Process | GO:0006629 | Lipid metabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0006810 | Transport |
| Process | GO:0006886 | Intracellular protein transport |
| Process | GO:0006897 | Endocytosis |
| Process | GO:0006913 | Nucleocytoplasmic transport |
| Process | GO:0006915 | Apoptotic process |
| Process | GO:0006935 | Chemotaxis |
| Process | GO:0006950 | Response to stress |
| Process | GO:0006996 | Organelle organization |
| Process | GO:0007010 | Cytoskeleton organization |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007162 | Negative regulation of cell adhesion |
| Process | GO:0007163 | Establishment or maintenance of cell polarity |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007166 | Cell surface receptor signaling pathway |
| Process | GO:0007224 | Smoothened signaling pathway |
| Process | GO:0007227 | Signal transduction downstream of smoothened |
| Process | GO:0007228 | Positive regulation of hh target transcription factor activity |
| Process | GO:0007267 | Cell-cell signaling |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0007350 | Blastoderm segmentation |
| Process | GO:0007368 | Determination of left/right symmetry |
| Process | GO:0007389 | Pattern specification process |
| Process | GO:0007398 | Ectoderm development |
| Process | GO:0007399 | Nervous system development |
| Process | GO:0007405 | Neuroblast proliferation |
| Process | GO:0007409 | Axonogenesis |
| Process | GO:0007411 | Axon guidance |
| Process | GO:0007417 | Central nervous system development |
| Process | GO:0007420 | Brain development |
| Process | GO:0007423 | Sensory organ development |
| Process | GO:0007431 | Salivary gland development |
| Process | GO:0007435 | Salivary gland morphogenesis |
| Process | GO:0007440 | Foregut morphogenesis |
| Process | GO:0007442 | Hindgut morphogenesis |
| Process | GO:0007498 | Mesoderm development |
| Process | GO:0007502 | Digestive tract mesoderm development |
| Process | GO:0007507 | Heart development |
| Process | GO:0007517 | Muscle organ development |
| Process | GO:0007519 | Skeletal muscle tissue development |
| Process | GO:0007548 | Sex differentiation |
| Process | GO:0007596 | Blood coagulation |
| Process | GO:0007599 | Hemostasis |
| Process | GO:0008104 | Protein localization |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008202 | Steroid metabolic process |
| Process | GO:0008209 | Androgen metabolic process |
| Process | GO:0008219 | Cell death |
| Process | GO:0008283 | Cell population proliferation |
| Process | GO:0008284 | Positive regulation of cell population proliferation |
| Process | GO:0008285 | Negative regulation of cell population proliferation |
| Process | GO:0008544 | Epidermis development |
| Process | GO:0008589 | Regulation of smoothened signaling pathway |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009611 | Response to wounding |
| Process | GO:0009628 | Response to abiotic stimulus |
| Process | GO:0009653 | Anatomical structure morphogenesis |
| Process | GO:0009790 | Embryo development |
| Process | GO:0009792 | Embryo development ending in birth or egg hatching |
| Process | GO:0009798 | Axis specification |
| Process | GO:0009799 | Specification of symmetry |
| Process | GO:0009855 | Determination of bilateral symmetry |
| Process | GO:0009880 | Embryonic pattern specification |
| Process | GO:0009887 | Animal organ morphogenesis |
| Process | GO:0009888 | Tissue development |
| Process | GO:0009889 | Regulation of biosynthetic process |
| Process | GO:0009890 | Negative regulation of biosynthetic process |
| Process | GO:0009891 | Positive regulation of biosynthetic process |
| Process | GO:0009892 | Negative regulation of metabolic process |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009894 | Regulation of catabolic process |
| Process | GO:0009895 | Negative regulation of catabolic process |
| Process | GO:0009948 | Anterior/posterior axis specification |
| Process | GO:0009949 | Polarity specification of anterior/posterior axis |
| Process | GO:0009952 | Anterior/posterior pattern specification |
| Process | GO:0009953 | Dorsal/ventral pattern formation |
| Process | GO:0009966 | Regulation of signal transduction |
| Process | GO:0009967 | Positive regulation of signal transduction |
| Process | GO:0009968 | Negative regulation of signal transduction |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010001 | Glial cell differentiation |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010035 | Response to inorganic substance |
| Process | GO:0010038 | Response to metal ion |
| Process | GO:0010226 | Response to lithium ion |
| Process | GO:0010243 | Response to organonitrogen compound |
| Process | GO:0010463 | Mesenchymal cell proliferation |
| Process | GO:0010464 | Regulation of mesenchymal cell proliferation |
| Process | GO:0010467 | Gene expression |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010556 | Regulation of macromolecule biosynthetic process |
| Process | GO:0010557 | Positive regulation of macromolecule biosynthetic process |
| Process | GO:0010558 | Negative regulation of macromolecule biosynthetic process |
| Process | GO:0010594 | Regulation of endothelial cell migration |
| Process | GO:0010595 | Positive regulation of endothelial cell migration |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010605 | Negative regulation of macromolecule metabolic process |
| Process | GO:0010628 | Positive regulation of gene expression |
| Process | GO:0010629 | Negative regulation of gene expression |
| Process | GO:0010632 | Regulation of epithelial cell migration |
| Process | GO:0010634 | Positive regulation of epithelial cell migration |
| Process | GO:0010646 | Regulation of cell communication |
| Process | GO:0010647 | Positive regulation of cell communication |
| Process | GO:0010648 | Negative regulation of cell communication |
| Process | GO:0010720 | Positive regulation of cell development |
| Process | GO:0010817 | Regulation of hormone levels |
| Process | GO:0010874 | Regulation of cholesterol efflux |
| Process | GO:0010941 | Regulation of cell death |
| Process | GO:0012501 | Programmed cell death |
| Process | GO:0014003 | Oligodendrocyte development |
| Process | GO:0014013 | Regulation of gliogenesis |
| Process | GO:0014015 | Positive regulation of gliogenesis |
| Process | GO:0014032 | Neural crest cell development |
| Process | GO:0014033 | Neural crest cell differentiation |
| Process | GO:0014070 | Response to organic cyclic compound |
| Process | GO:0014706 | Striated muscle tissue development |
| Process | GO:0014855 | Striated muscle cell proliferation |
| Process | GO:0014856 | Skeletal muscle cell proliferation |
| Process | GO:0014857 | Regulation of skeletal muscle cell proliferation |
| Process | GO:0014858 | Positive regulation of skeletal muscle cell proliferation |
| Process | GO:0014902 | Myotube differentiation |
| Process | GO:0015031 | Protein transport |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016055 | Wnt signaling pathway |
| Process | GO:0016192 | Vesicle-mediated transport |
| Process | GO:0016331 | Morphogenesis of embryonic epithelium |
| Process | GO:0016477 | Cell migration |
| Process | GO:0016485 | Protein processing |
| Process | GO:0016539 | Intein-mediated protein splicing |
| Process | GO:0016540 | Protein autoprocessing |
| Process | GO:0019219 | Regulation of nucleobase-containing compound metabolic process |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019538 | Protein metabolic process |
| Process | GO:0021510 | Spinal cord development |
| Process | GO:0021511 | Spinal cord patterning |
| Process | GO:0021513 | Spinal cord dorsal/ventral patterning |
| Process | GO:0021514 | Ventral spinal cord interneuron differentiation |
| Process | GO:0021515 | Cell differentiation in spinal cord |
| Process | GO:0021517 | Ventral spinal cord development |
| Process | GO:0021521 | Ventral spinal cord interneuron specification |
| Process | GO:0021522 | Spinal cord motor neuron differentiation |
| Process | GO:0021532 | Neural tube patterning |
| Process | GO:0021534 | Cell proliferation in hindbrain |
| Process | GO:0021536 | Diencephalon development |
| Process | GO:0021537 | Telencephalon development |
| Process | GO:0021782 | Glial cell development |
| Process | GO:0021794 | Thalamus development |
| Process | GO:0021871 | Forebrain regionalization |
| Process | GO:0021903 | Rostrocaudal neural tube patterning |
| Process | GO:0021904 | Dorsal/ventral neural tube patterning |
| Process | GO:0021915 | Neural tube development |
| Process | GO:0021924 | Cell proliferation in external granule layer |
| Process | GO:0021930 | Cerebellar granule cell precursor proliferation |
| Process | GO:0021936 | Regulation of cerebellar granule cell precursor proliferation |
| Process | GO:0021937 | Cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
| Process | GO:0021938 | Smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation |
| Process | GO:0021940 | Positive regulation of cerebellar granule cell precursor proliferation |
| Process | GO:0021953 | Central nervous system neuron differentiation |
| Process | GO:0021978 | Telencephalon regionalization |
| Process | GO:0022006 | Zona limitans intrathalamica formation |
| Process | GO:0022008 | Neurogenesis |
| Process | GO:0022404 | Molting cycle process |
| Process | GO:0022405 | Hair cycle process |
| Process | GO:0022407 | Regulation of cell-cell adhesion |
| Process | GO:0022408 | Negative regulation of cell-cell adhesion |
| Process | GO:0022409 | Positive regulation of cell-cell adhesion |
| Process | GO:0022414 | Reproductive process |
| Process | GO:0022603 | Regulation of anatomical structure morphogenesis |
| Process | GO:0022612 | Gland morphogenesis |
| Process | GO:0023051 | Regulation of signaling |
| Process | GO:0023052 | Signaling |
| Process | GO:0023056 | Positive regulation of signaling |
| Process | GO:0023057 | Negative regulation of signaling |
| Process | GO:0030010 | Establishment of cell polarity |
| Process | GO:0030030 | Cell projection organization |
| Process | GO:0030097 | Hemopoiesis |
| Process | GO:0030098 | Lymphocyte differentiation |
| Process | GO:0030111 | Regulation of Wnt signaling pathway |
| Process | GO:0030154 | Cell differentiation |
| Process | GO:0030155 | Regulation of cell adhesion |
| Process | GO:0030162 | Regulation of proteolysis |
| Process | GO:0030177 | Positive regulation of Wnt signaling pathway |
| Process | GO:0030178 | Negative regulation of Wnt signaling pathway |
| Process | GO:0030182 | Neuron differentiation |
| Process | GO:0030217 | T cell differentiation |
| Process | GO:0030323 | Respiratory tube development |
| Process | GO:0030324 | Lung development |
| Process | GO:0030326 | Embryonic limb morphogenesis |
| Process | GO:0030334 | Regulation of cell migration |
| Process | GO:0030335 | Positive regulation of cell migration |
| Process | GO:0030336 | Negative regulation of cell migration |
| Process | GO:0030539 | Male genitalia development |
| Process | GO:0030850 | Prostate gland development |
| Process | GO:0030856 | Regulation of epithelial cell differentiation |
| Process | GO:0030878 | Thyroid gland development |
| Process | GO:0030900 | Forebrain development |
| Process | GO:0030901 | Midbrain development |
| Process | GO:0030902 | Hindbrain development |
| Process | GO:0030908 | Protein splicing |
| Process | GO:0031016 | Pancreas development |
| Process | GO:0031069 | Hair follicle morphogenesis |
| Process | GO:0031099 | Regeneration |
| Process | GO:0031100 | Animal organ regeneration |
| Process | GO:0031175 | Neuron projection development |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031324 | Negative regulation of cellular metabolic process |
| Process | GO:0031325 | Positive regulation of cellular metabolic process |
| Process | GO:0031326 | Regulation of cellular biosynthetic process |
| Process | GO:0031327 | Negative regulation of cellular biosynthetic process |
| Process | GO:0031328 | Positive regulation of cellular biosynthetic process |
| Process | GO:0031329 | Regulation of cellular catabolic process |
| Process | GO:0031330 | Negative regulation of cellular catabolic process |
| Process | GO:0032101 | Regulation of response to external stimulus |
| Process | GO:0032103 | Positive regulation of response to external stimulus |
| Process | GO:0032355 | Response to estradiol |
| Process | GO:0032368 | Regulation of lipid transport |
| Process | GO:0032369 | Negative regulation of lipid transport |
| Process | GO:0032371 | Regulation of sterol transport |
| Process | GO:0032372 | Negative regulation of sterol transport |
| Process | GO:0032374 | Regulation of cholesterol transport |
| Process | GO:0032375 | Negative regulation of cholesterol transport |
| Process | GO:0032386 | Regulation of intracellular transport |
| Process | GO:0032388 | Positive regulation of intracellular transport |
| Process | GO:0032434 | Regulation of proteasomal ubiquitin-dependent protein catabolic process |
| Process | GO:0032435 | Negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032526 | Response to retinoic acid |
| Process | GO:0032784 | Regulation of DNA-templated transcription, elongation |
| Process | GO:0032785 | Negative regulation of DNA-templated transcription, elongation |
| Process | GO:0032879 | Regulation of localization |
| Process | GO:0032880 | Regulation of protein localization |
| Process | GO:0032899 | Regulation of neurotrophin production |
| Process | GO:0032901 | Positive regulation of neurotrophin production |
| Process | GO:0032943 | Mononuclear cell proliferation |
| Process | GO:0032944 | Regulation of mononuclear cell proliferation |
| Process | GO:0032945 | Negative regulation of mononuclear cell proliferation |
| Process | GO:0032946 | Positive regulation of mononuclear cell proliferation |
| Process | GO:0032989 | Cellular component morphogenesis |
| Process | GO:0032990 | Cell part morphogenesis |
| Process | GO:0033002 | Muscle cell proliferation |
| Process | GO:0033036 | Macromolecule localization |
| Process | GO:0033077 | T cell differentiation in thymus |
| Process | GO:0033081 | Regulation of T cell differentiation in thymus |
| Process | GO:0033083 | Regulation of immature T cell proliferation |
| Process | GO:0033084 | Regulation of immature T cell proliferation in thymus |
| Process | GO:0033085 | Negative regulation of T cell differentiation in thymus |
| Process | GO:0033089 | Positive regulation of T cell differentiation in thymus |
| Process | GO:0033091 | Positive regulation of immature T cell proliferation |
| Process | GO:0033092 | Positive regulation of immature T cell proliferation in thymus |
| Process | GO:0033157 | Regulation of intracellular protein transport |
| Process | GO:0033365 | Protein localization to organelle |
| Process | GO:0033993 | Response to lipid |
| Process | GO:0034243 | Regulation of transcription elongation from RNA polymerase II promoter |
| Process | GO:0034244 | Negative regulation of transcription elongation from RNA polymerase II promoter |
| Process | GO:0034504 | Protein localization to nucleus |
| Process | GO:0034754 | Cellular hormone metabolic process |
| Process | GO:0035050 | Embryonic heart tube development |
| Process | GO:0035107 | Appendage morphogenesis |
| Process | GO:0035108 | Limb morphogenesis |
| Process | GO:0035112 | Genitalia morphogenesis |
| Process | GO:0035113 | Embryonic appendage morphogenesis |
| Process | GO:0035115 | Embryonic forelimb morphogenesis |
| Process | GO:0035116 | Embryonic hindlimb morphogenesis |
| Process | GO:0035136 | Forelimb morphogenesis |
| Process | GO:0035137 | Hindlimb morphogenesis |
| Process | GO:0035148 | Tube formation |
| Process | GO:0035239 | Tube morphogenesis |
| Process | GO:0035265 | Organ growth |
| Process | GO:0035270 | Endocrine system development |
| Process | GO:0035272 | Exocrine system development |
| Process | GO:0035282 | Segmentation |
| Process | GO:0035290 | Trunk segmentation |
| Process | GO:0035295 | Tube development |
| Process | GO:0035556 | Intracellular signal transduction |
| Process | GO:0035914 | Skeletal muscle cell differentiation |
| Process | GO:0036293 | Response to decreased oxygen levels |
| Process | GO:0036484 | Trunk neural crest cell migration |
| Process | GO:0040007 | Growth |
| Process | GO:0040011 | Locomotion |
| Process | GO:0040012 | Regulation of locomotion |
| Process | GO:0040013 | Negative regulation of locomotion |
| Process | GO:0040017 | Positive regulation of locomotion |
| Process | GO:0042060 | Wound healing |
| Process | GO:0042063 | Gliogenesis |
| Process | GO:0042098 | T cell proliferation |
| Process | GO:0042102 | Positive regulation of T cell proliferation |
| Process | GO:0042110 | T cell activation |
| Process | GO:0042127 | Regulation of cell population proliferation |
| Process | GO:0042129 | Regulation of T cell proliferation |
| Process | GO:0042130 | Negative regulation of T cell proliferation |
| Process | GO:0042176 | Regulation of protein catabolic process |
| Process | GO:0042177 | Negative regulation of protein catabolic process |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042303 | Molting cycle |
| Process | GO:0042306 | Regulation of protein import into nucleus |
| Process | GO:0042307 | Positive regulation of protein import into nucleus |
| Process | GO:0042330 | Taxis |
| Process | GO:0042445 | Hormone metabolic process |
| Process | GO:0042475 | Odontogenesis of dentin-containing tooth |
| Process | GO:0042476 | Odontogenesis |
| Process | GO:0042481 | Regulation of odontogenesis |
| Process | GO:0042633 | Hair cycle |
| Process | GO:0042692 | Muscle cell differentiation |
| Process | GO:0042733 | Embryonic digit morphogenesis |
| Process | GO:0042981 | Regulation of apoptotic process |
| Process | GO:0043009 | Chordate embryonic development |
| Process | GO:0043010 | Camera-type eye development |
| Process | GO:0043066 | Negative regulation of apoptotic process |
| Process | GO:0043067 | Regulation of programmed cell death |
| Process | GO:0043069 | Negative regulation of programmed cell death |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043368 | Positive T cell selection |
| Process | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment |
| Process | GO:0043383 | Negative T cell selection |
| Process | GO:0043583 | Ear development |
| Process | GO:0043586 | Tongue development |
| Process | GO:0043587 | Tongue morphogenesis |
| Process | GO:0043588 | Skin development |
| Process | GO:0044093 | Positive regulation of molecular function |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0045058 | T cell selection |
| Process | GO:0045059 | Positive thymic T cell selection |
| Process | GO:0045060 | Negative thymic T cell selection |
| Process | GO:0045061 | Thymic T cell selection |
| Process | GO:0045103 | Intermediate filament-based process |
| Process | GO:0045104 | Intermediate filament cytoskeleton organization |
| Process | GO:0045109 | Intermediate filament organization |
| Process | GO:0045165 | Cell fate commitment |
| Process | GO:0045184 | Establishment of protein localization |
| Process | GO:0045321 | Leukocyte activation |
| Process | GO:0045445 | Myoblast differentiation |
| Process | GO:0045471 | Response to ethanol |
| Process | GO:0045580 | Regulation of T cell differentiation |
| Process | GO:0045581 | Negative regulation of T cell differentiation |
| Process | GO:0045582 | Positive regulation of T cell differentiation |
| Process | GO:0045595 | Regulation of cell differentiation |
| Process | GO:0045596 | Negative regulation of cell differentiation |
| Process | GO:0045597 | Positive regulation of cell differentiation |
| Process | GO:0045619 | Regulation of lymphocyte differentiation |
| Process | GO:0045620 | Negative regulation of lymphocyte differentiation |
| Process | GO:0045621 | Positive regulation of lymphocyte differentiation |
| Process | GO:0045664 | Regulation of neuron differentiation |
| Process | GO:0045665 | Negative regulation of neuron differentiation |
| Process | GO:0045666 | Positive regulation of neuron differentiation |
| Process | GO:0045685 | Regulation of glial cell differentiation |
| Process | GO:0045687 | Positive regulation of glial cell differentiation |
| Process | GO:0045765 | Regulation of angiogenesis |
| Process | GO:0045766 | Positive regulation of angiogenesis |
| Process | GO:0045785 | Positive regulation of cell adhesion |
| Process | GO:0045861 | Negative regulation of proteolysis |
| Process | GO:0045880 | Positive regulation of smoothened signaling pathway |
| Process | GO:0045892 | Negative regulation of transcription, DNA-templated |
| Process | GO:0045893 | Positive regulation of transcription, DNA-templated |
| Process | GO:0045934 | Negative regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045935 | Positive regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045944 | Positive regulation of transcription by RNA polymerase II |
| Process | GO:0046532 | Regulation of photoreceptor cell differentiation |
| Process | GO:0046534 | Positive regulation of photoreceptor cell differentiation |
| Process | GO:0046631 | Alpha-beta T cell activation |
| Process | GO:0046632 | Alpha-beta T cell differentiation |
| Process | GO:0046634 | Regulation of alpha-beta T cell activation |
| Process | GO:0046635 | Positive regulation of alpha-beta T cell activation |
| Process | GO:0046636 | Negative regulation of alpha-beta T cell activation |
| Process | GO:0046637 | Regulation of alpha-beta T cell differentiation |
| Process | GO:0046638 | Positive regulation of alpha-beta T cell differentiation |
| Process | GO:0046639 | Negative regulation of alpha-beta T cell differentiation |
| Process | GO:0046649 | Lymphocyte activation |
| Process | GO:0046651 | Lymphocyte proliferation |
| Process | GO:0046661 | Male sex differentiation |
| Process | GO:0046822 | Regulation of nucleocytoplasmic transport |
| Process | GO:0046824 | Positive regulation of nucleocytoplasmic transport |
| Process | GO:0046907 | Intracellular transport |
| Process | GO:0048368 | Lateral mesoderm development |
| Process | GO:0048468 | Cell development |
| Process | GO:0048513 | Animal organ development |
| Process | GO:0048514 | Blood vessel morphogenesis |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048534 | Hematopoietic or lymphoid organ development |
| Process | GO:0048538 | Thymus development |
| Process | GO:0048546 | Digestive tract morphogenesis |
| Process | GO:0048557 | Embryonic digestive tract morphogenesis |
| Process | GO:0048562 | Embryonic organ morphogenesis |
| Process | GO:0048565 | Digestive tract development |
| Process | GO:0048566 | Embryonic digestive tract development |
| Process | GO:0048568 | Embryonic organ development |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048584 | Positive regulation of response to stimulus |
| Process | GO:0048585 | Negative regulation of response to stimulus |
| Process | GO:0048589 | Developmental growth |
| Process | GO:0048598 | Embryonic morphogenesis |
| Process | GO:0048608 | Reproductive structure development |
| Process | GO:0048617 | Embryonic foregut morphogenesis |
| Process | GO:0048634 | Regulation of muscle organ development |
| Process | GO:0048641 | Regulation of skeletal muscle tissue development |
| Process | GO:0048643 | Positive regulation of skeletal muscle tissue development |
| Process | GO:0048645 | Animal organ formation |
| Process | GO:0048646 | Anatomical structure formation involved in morphogenesis |
| Process | GO:0048663 | Neuron fate commitment |
| Process | GO:0048665 | Neuron fate specification |
| Process | GO:0048666 | Neuron development |
| Process | GO:0048667 | Cell morphogenesis involved in neuron differentiation |
| Process | GO:0048678 | Response to axon injury |
| Process | GO:0048699 | Generation of neurons |
| Process | GO:0048706 | Embryonic skeletal system development |
| Process | GO:0048708 | Astrocyte differentiation |
| Process | GO:0048709 | Oligodendrocyte differentiation |
| Process | GO:0048710 | Regulation of astrocyte differentiation |
| Process | GO:0048711 | Positive regulation of astrocyte differentiation |
| Process | GO:0048713 | Regulation of oligodendrocyte differentiation |
| Process | GO:0048714 | Positive regulation of oligodendrocyte differentiation |
| Process | GO:0048729 | Tissue morphogenesis |
| Process | GO:0048730 | Epidermis morphogenesis |
| Process | GO:0048731 | System development |
| Process | GO:0048732 | Gland development |
| Process | GO:0048736 | Appendage development |
| Process | GO:0048745 | Smooth muscle tissue development |
| Process | GO:0048754 | Branching morphogenesis of an epithelial tube |
| Process | GO:0048762 | Mesenchymal cell differentiation |
| Process | GO:0048806 | Genitalia development |
| Process | GO:0048808 | Male genitalia morphogenesis |
| Process | GO:0048812 | Neuron projection morphogenesis |
| Process | GO:0048839 | Inner ear development |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0048858 | Cell projection morphogenesis |
| Process | GO:0048859 | Formation of anatomical boundary |
| Process | GO:0048863 | Stem cell differentiation |
| Process | GO:0048864 | Stem cell development |
| Process | GO:0048869 | Cellular developmental process |
| Process | GO:0048870 | Cell motility |
| Process | GO:0048880 | Sensory system development |
| Process | GO:0050670 | Regulation of lymphocyte proliferation |
| Process | GO:0050671 | Positive regulation of lymphocyte proliferation |
| Process | GO:0050672 | Negative regulation of lymphocyte proliferation |
| Process | GO:0050673 | Epithelial cell proliferation |
| Process | GO:0050678 | Regulation of epithelial cell proliferation |
| Process | GO:0050679 | Positive regulation of epithelial cell proliferation |
| Process | GO:0050767 | Regulation of neurogenesis |
| Process | GO:0050769 | Positive regulation of neurogenesis |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050793 | Regulation of developmental process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050817 | Coagulation |
| Process | GO:0050863 | Regulation of T cell activation |
| Process | GO:0050865 | Regulation of cell activation |
| Process | GO:0050866 | Negative regulation of cell activation |
| Process | GO:0050867 | Positive regulation of cell activation |
| Process | GO:0050868 | Negative regulation of T cell activation |
| Process | GO:0050870 | Positive regulation of T cell activation |
| Process | GO:0050878 | Regulation of body fluid levels |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0050920 | Regulation of chemotaxis |
| Process | GO:0050921 | Positive regulation of chemotaxis |
| Process | GO:0051049 | Regulation of transport |
| Process | GO:0051050 | Positive regulation of transport |
| Process | GO:0051051 | Negative regulation of transport |
| Process | GO:0051090 | Regulation of DNA-binding transcription factor activity |
| Process | GO:0051091 | Positive regulation of DNA-binding transcription factor activity |
| Process | GO:0051093 | Negative regulation of developmental process |
| Process | GO:0051094 | Positive regulation of developmental process |
| Process | GO:0051146 | Striated muscle cell differentiation |
| Process | GO:0051147 | Regulation of muscle cell differentiation |
| Process | GO:0051148 | Negative regulation of muscle cell differentiation |
| Process | GO:0051149 | Positive regulation of muscle cell differentiation |
| Process | GO:0051150 | Regulation of smooth muscle cell differentiation |
| Process | GO:0051151 | Negative regulation of smooth muscle cell differentiation |
| Process | GO:0051152 | Positive regulation of smooth muscle cell differentiation |
| Process | GO:0051153 | Regulation of striated muscle cell differentiation |
| Process | GO:0051155 | Positive regulation of striated muscle cell differentiation |
| Process | GO:0051169 | Nuclear transport |
| Process | GO:0051170 | Import into nucleus |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051172 | Negative regulation of nitrogen compound metabolic process |
| Process | GO:0051173 | Positive regulation of nitrogen compound metabolic process |
| Process | GO:0051179 | Localization |
| Process | GO:0051222 | Positive regulation of protein transport |
| Process | GO:0051223 | Regulation of protein transport |
| Process | GO:0051234 | Establishment of localization |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051240 | Positive regulation of multicellular organismal process |
| Process | GO:0051241 | Negative regulation of multicellular organismal process |
| Process | GO:0051246 | Regulation of protein metabolic process |
| Process | GO:0051248 | Negative regulation of protein metabolic process |
| Process | GO:0051249 | Regulation of lymphocyte activation |
| Process | GO:0051250 | Negative regulation of lymphocyte activation |
| Process | GO:0051251 | Positive regulation of lymphocyte activation |
| Process | GO:0051252 | Regulation of RNA metabolic process |
| Process | GO:0051253 | Negative regulation of RNA metabolic process |
| Process | GO:0051254 | Positive regulation of RNA metabolic process |
| Process | GO:0051302 | Regulation of cell division |
| Process | GO:0051604 | Protein maturation |
| Process | GO:0051641 | Cellular localization |
| Process | GO:0051649 | Establishment of localization in cell |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0051781 | Positive regulation of cell division |
| Process | GO:0051960 | Regulation of nervous system development |
| Process | GO:0051962 | Positive regulation of nervous system development |
| Process | GO:0055123 | Digestive system development |
| Process | GO:0060020 | Bergmann glial cell differentiation |
| Process | GO:0060021 | Roof of mouth development |
| Process | GO:0060070 | Canonical Wnt signaling pathway |
| Process | GO:0060173 | Limb development |
| Process | GO:0060174 | Limb bud formation |
| Process | GO:0060251 | Regulation of glial cell proliferation |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060284 | Regulation of cell development |
| Process | GO:0060322 | Head development |
| Process | GO:0060341 | Regulation of cellular localization |
| Process | GO:0060405 | Regulation of penile erection |
| Process | GO:0060406 | Positive regulation of penile erection |
| Process | GO:0060425 | Lung morphogenesis |
| Process | GO:0060428 | Lung epithelium development |
| Process | GO:0060429 | Epithelium development |
| Process | GO:0060438 | Trachea development |
| Process | GO:0060439 | Trachea morphogenesis |
| Process | GO:0060441 | Epithelial tube branching involved in lung morphogenesis |
| Process | GO:0060442 | Branching involved in prostate gland morphogenesis |
| Process | GO:0060445 | Branching involved in salivary gland morphogenesis |
| Process | GO:0060447 | Bud outgrowth involved in lung branching |
| Process | GO:0060458 | Right lung development |
| Process | GO:0060459 | Left lung development |
| Process | GO:0060462 | Lung lobe development |
| Process | GO:0060463 | Lung lobe morphogenesis |
| Process | GO:0060484 | Lung-associated mesenchyme development |
| Process | GO:0060485 | Mesenchyme development |
| Process | GO:0060512 | Prostate gland morphogenesis |
| Process | GO:0060516 | Primary prostatic bud elongation |
| Process | GO:0060523 | Prostate epithelial cord elongation |
| Process | GO:0060537 | Muscle tissue development |
| Process | GO:0060538 | Skeletal muscle organ development |
| Process | GO:0060541 | Respiratory system development |
| Process | GO:0060548 | Negative regulation of cell death |
| Process | GO:0060560 | Developmental growth involved in morphogenesis |
| Process | GO:0060562 | Epithelial tube morphogenesis |
| Process | GO:0060573 | Cell fate specification involved in pattern specification |
| Process | GO:0060579 | Ventral spinal cord interneuron fate commitment |
| Process | GO:0060581 | Cell fate commitment involved in pattern specification |
| Process | GO:0060602 | Branch elongation of an epithelium |
| Process | GO:0060605 | Tube lumen cavitation |
| Process | GO:0060662 | Salivary gland cavitation |
| Process | GO:0060664 | Epithelial cell proliferation involved in salivary gland morphogenesis |
| Process | GO:0060675 | Ureteric bud morphogenesis |
| Process | GO:0060684 | Epithelial-mesenchymal cell signaling |
| Process | GO:0060685 | Regulation of prostatic bud formation |
| Process | GO:0060688 | Regulation of morphogenesis of a branching structure |
| Process | GO:0060736 | Prostate gland growth |
| Process | GO:0060737 | Prostate gland morphogenetic growth |
| Process | GO:0060738 | Epithelial-mesenchymal signaling involved in prostate gland development |
| Process | GO:0060740 | Prostate gland epithelium morphogenesis |
| Process | GO:0060767 | Epithelial cell proliferation involved in prostate gland development |
| Process | GO:0060768 | Regulation of epithelial cell proliferation involved in prostate gland development |
| Process | GO:0060769 | Positive regulation of epithelial cell proliferation involved in prostate gland development |
| Process | GO:0060782 | Regulation of mesenchymal cell proliferation involved in prostate gland development |
| Process | GO:0060783 | Mesenchymal smoothened signaling pathway involved in prostate gland development |
| Process | GO:0060828 | Regulation of canonical Wnt signaling pathway |
| Process | GO:0060840 | Artery development |
| Process | GO:0060916 | Mesenchymal cell proliferation involved in lung development |
| Process | GO:0060993 | Kidney morphogenesis |
| Process | GO:0061008 | Hepaticobiliary system development |
| Process | GO:0061053 | Somite development |
| Process | GO:0061061 | Muscle structure development |
| Process | GO:0061136 | Regulation of proteasomal protein catabolic process |
| Process | GO:0061138 | Morphogenesis of a branching epithelium |
| Process | GO:0061189 | Positive regulation of sclerotome development |
| Process | GO:0061190 | Regulation of sclerotome development |
| Process | GO:0061196 | Fungiform papilla development |
| Process | GO:0061197 | Fungiform papilla morphogenesis |
| Process | GO:0061198 | Fungiform papilla formation |
| Process | GO:0061326 | Renal tubule development |
| Process | GO:0061333 | Renal tubule morphogenesis |
| Process | GO:0061351 | Neural precursor cell proliferation |
| Process | GO:0061371 | Determination of heart left/right asymmetry |
| Process | GO:0061458 | Reproductive system development |
| Process | GO:0061525 | Hindgut development |
| Process | GO:0061564 | Axon development |
| Process | GO:0065001 | Specification of axis polarity |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0070201 | Regulation of establishment of protein localization |
| Process | GO:0070445 | Regulation of oligodendrocyte progenitor proliferation |
| Process | GO:0070447 | Positive regulation of oligodendrocyte progenitor proliferation |
| Process | GO:0070482 | Response to oxygen levels |
| Process | GO:0070661 | Leukocyte proliferation |
| Process | GO:0070663 | Regulation of leukocyte proliferation |
| Process | GO:0070664 | Negative regulation of leukocyte proliferation |
| Process | GO:0070665 | Positive regulation of leukocyte proliferation |
| Process | GO:0070727 | Cellular macromolecule localization |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0071241 | Cellular response to inorganic substance |
| Process | GO:0071248 | Cellular response to metal ion |
| Process | GO:0071285 | Cellular response to lithium ion |
| Process | GO:0071679 | Commissural neuron axon guidance |
| Process | GO:0071702 | Organic substance transport |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0071705 | Nitrogen compound transport |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0072001 | Renal system development |
| Process | GO:0072006 | Nephron development |
| Process | GO:0072009 | Nephron epithelium development |
| Process | GO:0072028 | Nephron morphogenesis |
| Process | GO:0072044 | Collecting duct development |
| Process | GO:0072073 | Kidney epithelium development |
| Process | GO:0072074 | Kidney mesenchyme development |
| Process | GO:0072075 | Metanephric mesenchyme development |
| Process | GO:0072078 | Nephron tubule morphogenesis |
| Process | GO:0072080 | Nephron tubule development |
| Process | GO:0072088 | Nephron epithelium morphogenesis |
| Process | GO:0072089 | Stem cell proliferation |
| Process | GO:0072091 | Regulation of stem cell proliferation |
| Process | GO:0072111 | Cell proliferation involved in kidney development |
| Process | GO:0072135 | Kidney mesenchymal cell proliferation |
| Process | GO:0072136 | Metanephric mesenchymal cell proliferation involved in metanephros development |
| Process | GO:0072163 | Mesonephric epithelium development |
| Process | GO:0072164 | Mesonephric tubule development |
| Process | GO:0072171 | Mesonephric tubule morphogenesis |
| Process | GO:0072175 | Epithelial tube formation |
| Process | GO:0072199 | Regulation of mesenchymal cell proliferation involved in ureter development |
| Process | GO:0072203 | Cell proliferation involved in metanephros development |
| Process | GO:0072205 | Metanephric collecting duct development |
| Process | GO:0072359 | Circulatory system development |
| Process | GO:0072594 | Establishment of protein localization to organelle |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0090090 | Negative regulation of canonical Wnt signaling pathway |
| Process | GO:0090162 | Establishment of epithelial cell polarity |
| Process | GO:0090316 | Positive regulation of intracellular protein transport |
| Process | GO:0090370 | Negative regulation of cholesterol efflux |
| Process | GO:0090497 | Mesenchymal cell migration |
| Process | GO:0090596 | Sensory organ morphogenesis |
| Process | GO:0090598 | Male anatomical structure morphogenesis |
| Process | GO:0097152 | Mesenchymal cell apoptotic process |
| Process | GO:0097190 | Apoptotic signaling pathway |
| Process | GO:0097305 | Response to alcohol |
| Process | GO:0097421 | Liver regeneration |
| Process | GO:0097435 | Supramolecular fiber organization |
| Process | GO:0097485 | Neuron projection guidance |
| Process | GO:0098528 | Skeletal muscle fiber differentiation |
| Process | GO:0098773 | Skin epidermis development |
| Process | GO:0120036 | Plasma membrane bounded cell projection organization |
| Process | GO:0120039 | Plasma membrane bounded cell projection morphogenesis |
| Process | GO:0150063 | Visual system development |
| Process | GO:0198738 | Cell-cell signaling by wnt |
| Process | GO:1900180 | Regulation of protein localization to nucleus |
| Process | GO:1900182 | Positive regulation of protein localization to nucleus |
| Process | GO:1901214 | Regulation of neuron death |
| Process | GO:1901215 | Negative regulation of neuron death |
| Process | GO:1901342 | Regulation of vasculature development |
| Process | GO:1901360 | Organic cyclic compound metabolic process |
| Process | GO:1901564 | Organonitrogen compound metabolic process |
| Process | GO:1901698 | Response to nitrogen compound |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1901799 | Negative regulation of proteasomal protein catabolic process |
| Process | GO:1901861 | Regulation of muscle tissue development |
| Process | GO:1901863 | Positive regulation of muscle tissue development |
| Process | GO:1902105 | Regulation of leukocyte differentiation |
| Process | GO:1902106 | Negative regulation of leukocyte differentiation |
| Process | GO:1902107 | Positive regulation of leukocyte differentiation |
| Process | GO:1902679 | Negative regulation of RNA biosynthetic process |
| Process | GO:1902680 | Positive regulation of RNA biosynthetic process |
| Process | GO:1902692 | Regulation of neuroblast proliferation |
| Process | GO:1903037 | Regulation of leukocyte cell-cell adhesion |
| Process | GO:1903038 | Negative regulation of leukocyte cell-cell adhesion |
| Process | GO:1903039 | Positive regulation of leukocyte cell-cell adhesion |
| Process | GO:1903050 | Regulation of proteolysis involved in protein catabolic process |
| Process | GO:1903051 | Negative regulation of proteolysis involved in protein catabolic process |
| Process | GO:1903131 | Mononuclear cell differentiation |
| Process | GO:1903506 | Regulation of nucleic acid-templated transcription |
| Process | GO:1903507 | Negative regulation of nucleic acid-templated transcription |
| Process | GO:1903508 | Positive regulation of nucleic acid-templated transcription |
| Process | GO:1903670 | Regulation of sprouting angiogenesis |
| Process | GO:1903672 | Positive regulation of sprouting angiogenesis |
| Process | GO:1903706 | Regulation of hemopoiesis |
| Process | GO:1903707 | Negative regulation of hemopoiesis |
| Process | GO:1903708 | Positive regulation of hemopoiesis |
| Process | GO:1903829 | Positive regulation of protein localization |
| Process | GO:1904018 | Positive regulation of vasculature development |
| Process | GO:1904338 | Regulation of dopaminergic neuron differentiation |
| Process | GO:1904339 | Negative regulation of dopaminergic neuron differentiation |
| Process | GO:1904951 | Positive regulation of establishment of protein localization |
| Process | GO:1905114 | Cell surface receptor signaling pathway involved in cell-cell signaling |
| Process | GO:1905327 | Tracheoesophageal septum formation |
| Process | GO:1905330 | Regulation of morphogenesis of an epithelium |
| Process | GO:1905952 | Regulation of lipid localization |
| Process | GO:1905953 | Negative regulation of lipid localization |
| Process | GO:2000026 | Regulation of multicellular organismal development |
| Process | GO:2000027 | Regulation of animal organ morphogenesis |
| Process | GO:2000058 | Regulation of ubiquitin-dependent protein catabolic process |
| Process | GO:2000059 | Negative regulation of ubiquitin-dependent protein catabolic process |
| Process | GO:2000061 | Regulation of ureter smooth muscle cell differentiation |
| Process | GO:2000062 | Negative regulation of ureter smooth muscle cell differentiation |
| Process | GO:2000063 | Positive regulation of ureter smooth muscle cell differentiation |
| Process | GO:2000145 | Regulation of cell motility |
| Process | GO:2000146 | Negative regulation of cell motility |
| Process | GO:2000147 | Positive regulation of cell motility |
| Process | GO:2000177 | Regulation of neural precursor cell proliferation |
| Process | GO:2000179 | Positive regulation of neural precursor cell proliferation |
| Process | GO:2000241 | Regulation of reproductive process |
| Process | GO:2000243 | Positive regulation of reproductive process |
| Process | GO:2000356 | Regulation of kidney smooth muscle cell differentiation |
| Process | GO:2000357 | Negative regulation of kidney smooth muscle cell differentiation |
| Process | GO:2000358 | Positive regulation of kidney smooth muscle cell differentiation |
| Process | GO:2000729 | Positive regulation of mesenchymal cell proliferation involved in ureter development |
| Process | GO:2001026 | Regulation of endothelial cell chemotaxis |
| Process | GO:2001028 | Positive regulation of endothelial cell chemotaxis |
| Process | GO:2001053 | Regulation of mesenchymal cell apoptotic process |
| Process | GO:2001054 | Negative regulation of mesenchymal cell apoptotic process |
| Process | GO:2001141 | Regulation of RNA biosynthetic process |
| Component | GO:0000139 | Golgi membrane |
| Component | GO:0005576 | Extracellular region |
| Component | GO:0005615 | Extracellular space |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005634 | Nucleus |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005783 | Endoplasmic reticulum |
| Component | GO:0005789 | Endoplasmic reticulum membrane |
| Component | GO:0005794 | Golgi apparatus |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0008021 | Synaptic vesicle |
| Component | GO:0009986 | Cell surface |
| Component | GO:0012505 | Endomembrane system |
| Component | GO:0016020 | Membrane |
| Component | GO:0030054 | Cell junction |
| Component | GO:0030133 | Transport vesicle |
| Component | GO:0030312 | External encapsulating structure |
| Component | GO:0030424 | Axon |
| Component | GO:0030425 | Dendrite |
| Component | GO:0031012 | Extracellular matrix |
| Component | GO:0031090 | Organelle membrane |
| Component | GO:0031410 | Cytoplasmic vesicle |
| Component | GO:0031982 | Vesicle |
| Component | GO:0031984 | Organelle subcompartment |
| Component | GO:0036477 | Somatodendritic compartment |
| Component | GO:0042175 | Nuclear outer membrane-endoplasmic reticulum membrane network |
| Component | GO:0042995 | Cell projection |
| Component | GO:0043005 | Neuron projection |
| Component | GO:0043025 | Neuronal cell body |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0044297 | Cell body |
| Component | GO:0045121 | Membrane raft |
| Component | GO:0045202 | Synapse |
| Component | GO:0070382 | Exocytic vesicle |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097447 | Dendritic tree |
| Component | GO:0097708 | Intracellular vesicle |
| Component | GO:0098588 | Bounding membrane of organelle |
| Component | GO:0098793 | Presynapse |
| Component | GO:0098827 | Endoplasmic reticulum subcompartment |
| Component | GO:0098857 | Membrane microdomain |
| Component | GO:0099503 | Secretory vesicle |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:0120025 | Plasma membrane bounded cell projection |
| Function | GO:0003824 | Catalytic activity |
| Function | GO:0005102 | Signaling receptor binding |
| Function | GO:0005113 | Patched binding |
| Function | GO:0005488 | Binding |
| Function | GO:0005509 | Calcium ion binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0005539 | Glycosaminoglycan binding |
| Function | GO:0008233 | Peptidase activity |
| Function | GO:0008270 | Zinc ion binding |
| Function | GO:0016787 | Hydrolase activity |
| Function | GO:0043167 | Ion binding |
| Function | GO:0043169 | Cation binding |
| Function | GO:0043236 | Laminin binding |
| Function | GO:0043237 | laminin-1 binding |
| Function | GO:0046872 | Metal ion binding |
| Function | GO:0046914 | Transition metal ion binding |
| Function | GO:0050840 | Extracellular matrix binding |
| Function | GO:0097367 | Carbohydrate derivative binding |
| Function | GO:0140096 | Catalytic activity, acting on a protein |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-162582 | Signal Transduction |
| RCTM | RNO-5358346 | Hedgehog ligand biogenesis |
| RCTM | RNO-5358351 | Signaling by Hedgehog |
| RCTM | RNO-5362798 | Release of Hh-Np from the secreting cell |
| RCTM | RNO-5632681 | Ligand-receptor interactions |
| RCTM | RNO-5632684 | Hedgehog on state |
| RCTM | RNO-5635838 | Activation of SMO |
| WikiPathways | WP574 | Hedgehog signaling pathway |
| KEGG | rno04340 | Hedgehog signaling pathway |
| KEGG | rno04360 | Axon guidance |
| KEGG | rno05200 | Pathways in cancer |
| KEGG | rno05205 | Proteoglycans in cancer |
| KEGG | rno05217 | Basal cell carcinoma |
| KEGG | rno05226 | Gastric cancer |
Expression profile of Shh in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 3.9263206 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 4.4852195 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 4.6342993 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 4.8551354 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 4.9025335 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 4.6614985 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 4.986536 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 5.043018 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 5.21667 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 4.714138 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 5.1635942 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 4.9538684 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 5.1415105 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 5.187738 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 5.36563 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 5.121891 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 5.433457 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 5.009023 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 5.002535 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 4.951908 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 4.868658 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 5.187461 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 4.804192 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 4.962637 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 4.655298736 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 4.484724773 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 4.488538953 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.324337975 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.307273446 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.502541378 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 2.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 5.891187 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 5.919714 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 5.955035 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 6.074811 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 6.015792 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 5.892368 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 10.116 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 5.107 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 7.582 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 9.59 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 8.852 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 1.274761596 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 2.011604913 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 1.741946137 |
| ID | GSE1616 |
| Title | Genomics of preconditioning |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM27484 | APC_a (anesthetic-preconditioning, 1st replicate) | 109.9 | |
| GSM27485 | APC_b (anesthetic-preconditioning, 2nd replicate) | 101.6 | |
| GSM27486 | APC_c (anesthetic-preconditioning, 3rd replicate) | 122.6 | |
| GSM27487 | APC_d (anesthetic-preconditioning, 4th replicate) | 124.3 | |
| GSM27488 | APC_e (anesthetic-preconditioning, 5th replicate) | 131.0 | |
| GSM27489 | APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) | 200.7 | |
| GSM27490 | APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) | 87.3 | |
| GSM27491 | APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) | 125.3 | |
| GSM27492 | APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) | 142.4 | |
| GSM27493 | APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) | 193.5 | |
| GSM27494 | CTL_a (control, 1st replicate) | 136.5 | |
| GSM27495 | CTL_b (control, 2nd replicate) | 133.5 | |
| GSM27496 | CTL_c (control, 3rd replicate) | 105.7 | |
| GSM27497 | CTL_d (control, 4th replicate) | 104.3 | |
| GSM27498 | CTL_e (control, 5th replicate) | 140.5 | |
| GSM27499 | IPC_a (ischemic preconditioning, 1st replicate) | 147.5 | |
| GSM27500 | IPC_b (ischemic preconditioning, 2nd replicate) | 137.5 | |
| GSM27501 | IPC_c (ischemic preconditioning, 3rd replicate) | 130.4 | |
| GSM27502 | IPC_d (ischemic preconditioning, 4th replicate) | 144.6 | |
| GSM27503 | IPC_e (ischemic preconditioning, 5th replicate) | 194.7 | |
| GSM27504 | IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) | 267.2 | |
| GSM27505 | IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) | 110.5 | |
| GSM27506 | IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) | 176.3 | |
| GSM27507 | IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) | 186.5 | |
| GSM27508 | IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) | 170.9 | |
| GSM27509 | ISCH_a (ischemia, 1st replicate) | 163.7 | |
| GSM27510 | ISCH_b (ischemia, 2nd replicate) | 114.0 | |
| GSM27511 | ISCH_c (ischemia, 3rd replicate) | 112.5 | |
| GSM27512 | ISCH_d (ischemia, 4th replicate) | 165.9 | |
| GSM27513 | ISCH_e (ischemia, 5th replicate) | 156.3 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 5.7 |
| GSM30791 | baseline control 02 | male, 275-300g | 6.8 |
| GSM30792 | baseline control 03 | male, 275-300g | 6.6 |
| GSM30793 | baseline control 04 | male, 275-300g | 11.4 |
| GSM30794 | baseline control 05 | male, 275-300g | 4.8 |
| GSM30795 | baseline control 06 | male, 275-300g | 3.2 |
| GSM30796 | baseline control 07 | male, 275-300g | 3.5 |
| GSM30797 | baseline control 08 | male, 275-300g | 4.1 |
| GSM30798 | baseline control 09 | male, 275-300g | 4.7 |
| GSM30799 | pain 01 | 8.6 | |
| GSM30800 | pain 02 | 5.3 | |
| GSM30801 | pain 03 | 21.2 | |
| GSM30802 | pain 04 | 5.9 | |
| GSM30803 | pain 05 | 9.7 | |
| GSM30804 | FC 01 | 12.1 | |
| GSM30805 | FC 02 | 7.4 | |
| GSM30806 | FC 03 | 5.8 | |
| GSM30807 | FC 04 | 7.3 | |
| GSM30808 | FC 05 | 7.9 | |
| GSM30809 | IFC 01 | 10.9 | |
| GSM30810 | IFC 02 | 6.5 | |
| GSM30811 | IFC 03 | 7.0 | |
| GSM30812 | IFC 04 | 7.8 | |
| GSM30813 | IFC 05 | 9.0 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 3.2 |
| GSM99801 | isoflurane 02 | male, 275-300g | 7.7 |
| GSM99802 | isoflurane 03 | male, 275-300g | 9.1 |
| GSM99803 | isoflurane 04 | male, 275-300g | 5.8 |
| GSM99804 | isoflurane 05 | male, 275-300g | 3.3 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 5.204 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 5.1151 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 4.7662 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 5.5387 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 5.1814 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 5.0234 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 5.2471 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 5.0994 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 4.6901 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 5.79146 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 5.80392 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 4.16272 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 4.08411 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 5.29074 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 5.42489 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 7.53142 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 7.07624 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 6.25926 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 6.25501 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 4.74826 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 3.96181 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 5.47156 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 5.22642 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 7.67784 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 7.24198 |
| ID | GSE205202 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat] |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208507 | Rat_Baseline_0h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.579724 |
| GSM6208508 | Rat_Baseline_0h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.767797 |
| GSM6208509 | Rat_Baseline_0h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.659379 |
| GSM6208510 | Rat_Baseline_0h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.590852 |
| GSM6208511 | Rat_Baseline_0h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 4.83135 |
| GSM6208512 | Rat_Vehicle_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.664111 |
| GSM6208513 | Rat_Vehicle_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.763485 |
| GSM6208514 | Rat_Vehicle_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.736341 |
| GSM6208515 | Rat_Vehicle_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.559658 |
| GSM6208516 | Rat_Vehicle_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 4.681284 |
| GSM6208517 | Rat_Vehicle_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.627303 |
| GSM6208518 | Rat_Vehicle_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.591768 |
| GSM6208519 | Rat_Vehicle_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.697205 |
| GSM6208520 | Rat_Vehicle_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.755971 |
| GSM6208521 | Rat_Vehicle_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 4.713056 |
| GSM6208522 | Rat_Vehicle_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.631345 |
| GSM6208523 | Rat_Vehicle_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.726914 |
| GSM6208524 | Rat_Vehicle_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.583006 |
| GSM6208525 | Rat_Vehicle_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.742181 |
| GSM6208526 | Rat_Vehicle_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 4.7378 |
| GSM6208527 | Rat_Vehicle_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.491707 |
| GSM6208528 | Rat_Vehicle_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.688938 |
| GSM6208529 | Rat_Vehicle_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.658632 |
| GSM6208530 | Rat_Vehicle_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.573646 |
| GSM6208531 | Rat_Vehicle_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 4.671373 |
| GSM6208532 | Rat_APAP_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.735662 |
| GSM6208533 | Rat_APAP_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.64677 |
| GSM6208534 | Rat_APAP_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.701598 |
| GSM6208535 | Rat_APAP_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.813098 |
| GSM6208536 | Rat_APAP_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 4.61324 |
| GSM6208537 | Rat_APAP_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.427682 |
| GSM6208538 | Rat_APAP_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.763928 |
| GSM6208539 | Rat_APAP_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.65421 |
| GSM6208540 | Rat_APAP_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.771429 |
| GSM6208541 | Rat_APAP_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 4.614538 |
| GSM6208542 | Rat_APAP_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.674265 |
| GSM6208543 | Rat_APAP_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.76651 |
| GSM6208544 | Rat_APAP_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.642146 |
| GSM6208545 | Rat_APAP_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.838559 |
| GSM6208546 | Rat_APAP_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 4.614223 |
| GSM6208547 | Rat_APAP_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.722749 |
| GSM6208548 | Rat_APAP_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.687885 |
| GSM6208549 | Rat_APAP_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.520918 |
| GSM6208550 | Rat_APAP_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.63126 |
| GSM6208551 | Rat_APAP_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 4.674729 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 3.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 6.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 10.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 8.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 7.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 12.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 5.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 8.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 9.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 13.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 10.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 8.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 11.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 5.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 12.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 6.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 7.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 10.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 4.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 15.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 9.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 9.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 6.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 14.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 10.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 9.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 13.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 14.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 5.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 13.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 13.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 9.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 14.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 15.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 11.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 8.0 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | 0.00592 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | -0.0566 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | -0.0225 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | 0.353 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | 0.0227 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | 0.0774 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | -0.0546 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | 0.0628 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | -0.0399 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | 0.0793 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | 0.0637 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | 0.0481 |
| ID | GSE359 |
| Title | Isoflurane Single Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5120 | Isoflurane single exposure control-1 | 61.6 | |
| GSM5121 | Isoflurane single exposure control-2 | 45.3 | |
| GSM5122 | Isoflurane single exposure control-3 | 51.4 | |
| GSM5124 | Isoflurane single exposure 1 hr-1 | 29.7 | |
| GSM5126 | Isoflurane single exposure 1 hr-2 | 67.5 | |
| GSM5127 | Isoflurane single exposure 2 hr-1 | 47.5 | |
| GSM5130 | Isoflurane single exposure 2 hr-2 | 92.6 | |
| GSM5131 | Isoflurane single exposure 2 hr-3 | 54.0 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.60901599 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.644219278 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.522458668 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.604288472 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.656017073 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.790089055 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.981286195 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.696057049 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.645038781 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.837445328 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 3.854515016 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 3.808705013 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.72863757 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.185856843 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.76588882 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.748483298 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 4.282837429 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.705667875 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.791820829 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.793020892 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.791440603 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.784414294 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.854515016 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.720546697 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.152797 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.354823 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.384655 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.018588 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.115897 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.165515 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.364163 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.306291 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.31669 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.276649 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.061839 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.093831 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.143367 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.228907 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.264662 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.36587 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.120513 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.151412 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.989355 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.263639 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.079725 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.179935 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.112689 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.179623 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 108.607 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 113.8277 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 5.613732868 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 2.969948139 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 4.422086654 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 4.205189057 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 2.76750287 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 5.870559942 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 7.164464842 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 6.472282355 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 3.235022367 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 3.680498805 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 4.808843172 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 4.445750772 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 3.272229803 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 5.979558086 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.60901599 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.644219278 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.522458668 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.604288472 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.656017073 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.790089055 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.981286195 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.696057049 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.645038781 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.837445328 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 3.854515016 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 3.808705013 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.72863757 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.185856843 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.76588882 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.748483298 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 4.282837429 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.705667875 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.791820829 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.793020892 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.791440603 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.784414294 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.854515016 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.720546697 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 5.613732868 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 2.969948139 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 4.422086654 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 4.205189057 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 2.76750287 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 5.870559942 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 7.164464842 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 6.472282355 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 3.235022367 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 3.680498805 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 4.808843172 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 4.445750772 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 3.272229803 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 5.979558086 |
| ID | GSE752 |
| Title | Halothane/Isoflurane Repetitive Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5082 | Control 1 | 68.3 | |
| GSM5084 | Control 2 | 65.6 | |
| GSM5085 | Control 3 | 77.8 | |
| GSM5086 | Control 4 | 48.3 | |
| GSM5087 | Control 5 | 57.5 | |
| GSM5090 | Control 6 | 63.6 | |
| GSM5105 | Control 7 | 46.8 | |
| GSM5106 | Control 8 | 68.1 | |
| GSM5107 | Control 9 | 86.2 | |
| GSM5108 | Halothane 10 exposure-1 | 46.3 | |
| GSM5109 | Halothane 10 exposures-2 | 62.1 | |
| GSM5110 | Halothane 10 exposures-3 | 63.8 | |
| GSM5111 | Halothane 5 exposures-1 | 81.7 | |
| GSM5112 | Halothane 5 exposures-2 | 50.2 | |
| GSM5113 | Halothane 5 exposures-3 | 71.8 | |
| GSM5114 | Isoflurane 10 exposures-1 | 61.9 | |
| GSM5115 | Isoflurane 10 exposures-2 | 60.5 | |
| GSM5116 | Isoflurane 10 exposures-3 | 58.0 | |
| GSM5117 | Isoflurane 5 exposures-1 | 61.3 | |
| GSM5118 | Isoflurane 5 exposures-2 | 60.4 | |
| GSM5119 | Isoflurane 5 exposures-3 | 79.3 | |
| GSM11379 | Control 10 | 85.3 | |
| GSM11380 | Control 11 | 29.9 | |
| GSM11381 | Control 12 | 86.7 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 0.893574 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 2.69442 |
